These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11508155)

  • 21. [Immunohistochemical study of lesions in Horton's temporal arteritis before and during corticotherapy].
    Lavignac C; Jauberteau-Marchan MO; Liozon E; Vidal E; Catanzano G; Liozon F
    Rev Med Interne; 1996; 17(10):814-20. PubMed ID: 8976974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.
    Martínez-Taboada VM; Rodríguez-Valverde V; Carreño L; López-Longo J; Figueroa M; Belzunegui J; Mola EM; Bonilla G
    Ann Rheum Dis; 2008 May; 67(5):625-30. PubMed ID: 18086726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between histological subtypes and clinical characteristics at presentation and outcome in biopsy-proven temporal arteritis. Identification of a relatively benign subgroup.
    ter Borg EJ; Haanen HC; Seldenrijk CA
    Clin Rheumatol; 2007 Apr; 26(4):529-32. PubMed ID: 16816887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Giant cell arteritis (Horton's disease) in very elderly patients aged 80 years and older: A study of 25 cases.
    Muller G; Devilliers H; Besancenot JF; Manckoundia P
    Geriatr Gerontol Int; 2016 Jun; 16(6):679-85. PubMed ID: 26081629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases.
    Font RL; Prabhakaran VC
    Br J Ophthalmol; 2007 Feb; 91(2):204-9. PubMed ID: 16987903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BOB-ACG study: Pulse methylprednisolone to prevent bilateral ophthalmologic damage in giant cell arteritis. A multicentre retrospective study with propensity score analysis.
    Foré R; Liozon E; Dumonteil S; Sené T; Héron E; Lacombe V; Leclercq M; Magnant J; Beuvon C; Régent A; de Mornac D; Samson M; Smets P; Alexandra JF; Granel B; Robert PY; Curumthaullee MF; Parreau S; Palat S; Bezanahary H; Ly KH; Fauchais AL; ; Gondran G
    Joint Bone Spine; 2024 Jan; 91(1):105641. PubMed ID: 37734440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged corticosteroid treatment in the management of temporal arteritis.
    Friedman G; Friedman B
    Klin Wochenschr; 1988 Dec; 66(23):1167-70. PubMed ID: 3145360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Horton's disease revealed by brachial C5 plexopathy].
    Blaise S; Liozon E; Nadalon S; Vidal E
    Rev Med Interne; 2005 Jul; 26(7):578-82. PubMed ID: 15953663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Place of azathioprine in the treatment of giant cell arteritis].
    Boureau AS; de Faucal P; Espitia O; De Decker L; Agard C
    Rev Med Interne; 2016 Nov; 37(11):723-729. PubMed ID: 27260788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
    Brauer VF; Scholz GH
    Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies.
    Hayreh SS; Zimmerman B
    Ophthalmologica; 2003; 217(4):239-59. PubMed ID: 12792130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications of corticosteroid therapy in presumptive temporal arteritis.
    Brownstein S; Vine AK
    Can J Ophthalmol; 1976 Apr; 11(2):115-21. PubMed ID: 1078327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of complicated Horton's disease].
    Généreau T
    Rev Prat; 1999 Mar; 49(6):618-22. PubMed ID: 10218399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated renal giant cell arteritis.
    Medvedev G; Al-Shamari AE; Copland MA; Magil AB
    Am J Kidney Dis; 2002 Sep; 40(3):658-61. PubMed ID: 12200821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone.
    Cornblath WT; Eggenberger ER
    Ophthalmology; 1997 May; 104(5):854-8. PubMed ID: 9160034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bilateral amaurosis in 11 patients with giant cell arteritis confirmed by arterial biopsy].
    Wenkel H
    Klin Monbl Augenheilkd; 2001 Oct; 218(10):658-61. PubMed ID: 11706381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy.
    Hayreh SS; Zimmerman B
    Ophthalmology; 2003 Jun; 110(6):1204-15. PubMed ID: 12799248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy.
    Kupersmith MJ; Langer R; Mitnick H; Spiera R; Spiera H; Richmond M; Paget S
    Br J Ophthalmol; 1999 Jul; 83(7):796-801. PubMed ID: 10381666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?
    Achkar AA; Lie JT; Hunder GG; O'Fallon WM; Gabriel SE
    Ann Intern Med; 1994 Jun; 120(12):987-92. PubMed ID: 8185147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Horton's bitemporal arteritis. A case report].
    Carmenini G; Martusciello S; Di Maio F; Scioli A; Nicoletti M; Meloni F
    Recenti Prog Med; 1992 Oct; 83(10):559-63. PubMed ID: 1462039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.